1. Home
  2. VERB vs GLMD Comparison

VERB vs GLMD Comparison

Compare VERB & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERB
  • GLMD
  • Stock Information
  • Founded
  • VERB 2014
  • GLMD 2000
  • Country
  • VERB United States
  • GLMD Israel
  • Employees
  • VERB N/A
  • GLMD N/A
  • Industry
  • VERB Other Consumer Services
  • GLMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • VERB Consumer Discretionary
  • GLMD Health Care
  • Exchange
  • VERB Nasdaq
  • GLMD Nasdaq
  • Market Cap
  • VERB 4.7M
  • GLMD 4.6M
  • IPO Year
  • VERB N/A
  • GLMD 2014
  • Fundamental
  • Price
  • VERB $5.94
  • GLMD $2.98
  • Analyst Decision
  • VERB Strong Buy
  • GLMD
  • Analyst Count
  • VERB 1
  • GLMD 0
  • Target Price
  • VERB $100.00
  • GLMD N/A
  • AVG Volume (30 Days)
  • VERB 93.4K
  • GLMD 40.5K
  • Earning Date
  • VERB 11-05-2024
  • GLMD 12-27-2024
  • Dividend Yield
  • VERB N/A
  • GLMD N/A
  • EPS Growth
  • VERB N/A
  • GLMD N/A
  • EPS
  • VERB N/A
  • GLMD N/A
  • Revenue
  • VERB $201,000.00
  • GLMD N/A
  • Revenue This Year
  • VERB $547.62
  • GLMD N/A
  • Revenue Next Year
  • VERB $200.00
  • GLMD N/A
  • P/E Ratio
  • VERB N/A
  • GLMD N/A
  • Revenue Growth
  • VERB 415.38
  • GLMD N/A
  • 52 Week Low
  • VERB $5.05
  • GLMD $2.56
  • 52 Week High
  • VERB $184.60
  • GLMD $23.80
  • Technical
  • Relative Strength Index (RSI)
  • VERB 35.34
  • GLMD 51.13
  • Support Level
  • VERB $5.81
  • GLMD $2.73
  • Resistance Level
  • VERB $8.31
  • GLMD $3.07
  • Average True Range (ATR)
  • VERB 0.77
  • GLMD 0.23
  • MACD
  • VERB -0.18
  • GLMD 0.08
  • Stochastic Oscillator
  • VERB 12.46
  • GLMD 66.69

About VERB Verb Technology Company Inc.

Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. Available in over 60 countries and in mobile and desktop versions, it includes verbLIVE an interactive livestream eCommerce, shoppable video and webinar, verbCRM a customer relationship management, verbTEAMS a self on-boarding version of verbCRM with built-in verbLIVE and salesforce synchronization for small businesses, verbLEARN a learning management system and among others.

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

Share on Social Networks: